Profile
Matthew Panuwat is currently Chief Business Officer at Oric Pharmaceuticals, Inc., a position held since 2018.
Formerly, Mr. Panuwat was Head of Business Development at Medivation LLC (California) and Senior Vice President of Business Development at Prothena Corp.
Plc from 2017 to 2018.
Education includes an MBA from the University of California, Los Angeles, an undergraduate degree from Santa Clara University, and graduate studies at Georgetown University.
Matthew Panuwat active positions
| Companies | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2018 |
Former positions of Matthew Panuwat
| Companies | Position | End |
|---|---|---|
| PROTHENA CORPORATION PLC | Corporate Officer/Principal | 01/11/2018 |
| MEDIVATION INC | Corporate Officer/Principal | - |
Training of Matthew Panuwat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Prothena Corp. Plc
Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Matthew Panuwat
















